David Pei‐Cheng Lin

11.2k total citations · 2 hit papers
59 papers, 9.5k citations indexed

About

David Pei‐Cheng Lin is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, David Pei‐Cheng Lin has authored 59 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Public Health, Environmental and Occupational Health and 9 papers in Oncology. Recurrent topics in David Pei‐Cheng Lin's work include Ocular Surface and Contact Lens (9 papers), Cancer-related Molecular Pathways (7 papers) and Epigenetics and DNA Methylation (7 papers). David Pei‐Cheng Lin is often cited by papers focused on Ocular Surface and Contact Lens (9 papers), Cancer-related Molecular Pathways (7 papers) and Epigenetics and DNA Methylation (7 papers). David Pei‐Cheng Lin collaborates with scholars based in Taiwan, United States and Japan. David Pei‐Cheng Lin's co-authors include W E Mercer, K W Kinzler, Wafik S. El‐Deiry, J.M. Trent, Bert Vogelstein, Takashi Tokino, Victor E. Velculescu, Ramon Parsons, Daniel B. Levy and Paolo Michieli and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

David Pei‐Cheng Lin

55 papers receiving 9.4k citations

Hit Papers

WAF1, a potential mediato... 1993 2026 2004 2015 1993 1994 2.0k 4.0k 6.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Pei‐Cheng Lin Taiwan 20 6.7k 6.2k 1.6k 1.3k 739 59 9.5k
Xinbin Chen United States 56 7.5k 1.1× 4.4k 0.7× 1.9k 1.2× 977 0.7× 625 0.8× 176 9.8k
Takashi Tokino Japan 10 6.0k 0.9× 5.4k 0.9× 1.3k 0.8× 1.2k 0.9× 694 0.9× 14 8.1k
Stephen N. Jones United States 50 10.6k 1.6× 5.9k 1.0× 2.4k 1.5× 1.1k 0.9× 1.1k 1.5× 114 13.2k
Daniel B. Levy United States 10 6.2k 0.9× 5.8k 0.9× 1.6k 1.0× 1.1k 0.9× 753 1.0× 13 9.1k
Sandy Chang United States 46 7.6k 1.1× 3.2k 0.5× 1.4k 0.9× 764 0.6× 767 1.0× 88 11.3k
Samuel Benchimol Canada 46 5.7k 0.8× 4.6k 0.7× 1.4k 0.9× 1.2k 0.9× 447 0.6× 94 8.8k
Ada Sacchi Italy 55 5.8k 0.9× 3.7k 0.6× 1.5k 0.9× 868 0.7× 1.2k 1.7× 162 8.4k
Sheau-Yann Shieh Taiwan 28 6.2k 0.9× 4.6k 0.7× 1.3k 0.8× 774 0.6× 1.1k 1.5× 39 7.4k
Peter M. Chumakov Russia 38 4.6k 0.7× 3.0k 0.5× 1.3k 0.8× 822 0.6× 557 0.8× 175 6.7k
Laura D. Attardi United States 48 9.4k 1.4× 4.3k 0.7× 3.9k 2.4× 790 0.6× 920 1.2× 104 12.4k

Countries citing papers authored by David Pei‐Cheng Lin

Since Specialization
Citations

This map shows the geographic impact of David Pei‐Cheng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Pei‐Cheng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Pei‐Cheng Lin more than expected).

Fields of papers citing papers by David Pei‐Cheng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Pei‐Cheng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Pei‐Cheng Lin. The network helps show where David Pei‐Cheng Lin may publish in the future.

Co-authorship network of co-authors of David Pei‐Cheng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of David Pei‐Cheng Lin. A scholar is included among the top collaborators of David Pei‐Cheng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Pei‐Cheng Lin. David Pei‐Cheng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Lin, David Pei‐Cheng, et al.. (2024). Current updates for hyperuricemia and gout in age‐related macular degeneration. The FASEB Journal. 38(10). e23676–e23676. 3 indexed citations
4.
Lin, David Pei‐Cheng, et al.. (2024). Hepatic inflammation, ballooning, and pyknosis caused by LED light exposure in a mouse model, with differential effects by age and gender. Ecotoxicology and Environmental Safety. 284. 116984–116984.
5.
Chen, Zhijia, et al.. (2023). Klotho Null Mutation Indirectly Leads to Age-Related Lacrimal Gland Degeneration in Mutant Mice. Biology. 12(10). 1328–1328. 2 indexed citations
6.
Li, Tsung‐Ju, Li‐Ya Lee, Yen‐Lien Chen, et al.. (2023). Preventative Effects of Cordyceps cicadae Mycelial Extracts on the Early-Stage Development of Cataracts in UVB-Induced Mice Cataract Model. Nutrients. 15(14). 3103–3103. 3 indexed citations
7.
Su, Yu-Shan, et al.. (2022). Short-Term Hyperuricemia Leads to Structural Retinal Changes That Can be Reversed by Serum Uric Acid Lowering Agents in Mice. Investigative Ophthalmology & Visual Science. 63(10). 8–8. 6 indexed citations
8.
Lai, Keane K. Y., Cu Nguyen, David Pei‐Cheng Lin, et al.. (2021). p300 Serine 89: A Critical Signaling Integrator and Its Effects on Intestinal Homeostasis and Repair. Cancers. 13(6). 1288–1288. 11 indexed citations
9.
Lin, David Pei‐Cheng, et al.. (2020). Safety Assessment of HEA-Enriched Cordyceps cicadae Mycelium: A Randomized Clinical Trial. Journal of the American College of Nutrition. 40(2). 127–132. 16 indexed citations
10.
Li, I-Chen, Han‐Hsin Chang, Wan‐Ping Chen, et al.. (2020). Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study. Frontiers in Aging Neuroscience. 12. 155–155. 72 indexed citations
11.
Lukaszewicz, Agnès, Cu Nguyen, David Pei‐Cheng Lin, et al.. (2019). The Mode of Stem Cell Division Is Dependent on the Differential Interaction of β-Catenin with the Kat3 Coactivators CBP or p300. Cancers. 11(7). 962–962. 10 indexed citations
12.
Ono, Masaya, Keane K. Y. Lai, Kaijin Wu, et al.. (2018). Nuclear receptor/Wnt beta-catenin interactions are regulated via differential CBP/p300 coactivator usage. PLoS ONE. 13(7). e0200714–e0200714. 17 indexed citations
13.
Manegold, Philipp, Keane K. Y. Lai, Yongfeng Wu, et al.. (2018). Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer. Cancers. 10(4). 95–95. 43 indexed citations
14.
Lin, David Pei‐Cheng, et al.. (2013). An 8‐week Brain MRI Follow‐up Analysis of Rat Eosinophilic Meningitis Caused byAngiostrongylus cantonensisInfection. Zoonoses and Public Health. 61(6). 411–419. 5 indexed citations
15.
Lin, David Pei‐Cheng, et al.. (2012). The effects of myopia and AC/A measuring methodology on AC/A ratio outcome. 23(2). 87–94. 2 indexed citations
17.
Lin, David Pei‐Cheng, et al.. (2010). Sonic Hedgehog improves in vitro development of porcine parthenotes and handmade cloned embryos. Theriogenology. 74(7). 1149–1160. 15 indexed citations
18.
Seely, Dugald, Deborah Kennedy, Stephen P Myers, et al.. (2008). In vitro analysis of the herbal compound Essiac.. PubMed. 27(6B). 3875–82. 7 indexed citations
19.
Chen, Bo-Yie, Han‐Hsin Chang, Hui‐Ling Chiou, & David Pei‐Cheng Lin. (2004). Influenza-B-Virus-Induced Eye and Brain Malformations during Early Chick Embryogenesis and Localization of the Viral RNA in Specific Areas. Journal of Biomedical Science. 11(2). 266–274. 5 indexed citations
20.
El‐Deiry, Wafik S., Takashi Tokino, Victor E. Velculescu, et al.. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell. 75(4). 817–825. 7234 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026